Home

Investigators' Global Assessment of
Atopic Dermatitis
 

eIGA for AD
 

Atopic dermatitis assessment made
easy and quick

eiga ios

iOS version
eiga android

Android version
eiga web

Web version
eiga pdf

Illustrative PDF

(coming soon)

eiga pdf or

Original PDF

(coming soon)

What is the eIGA for atopic dermatitis?

The Investigator Global Assessment (IGA) is a 6-point scoring system used to assess the severity of atopic dermatitis. The terms physician or investigator global assessment (IGA) may be used interchangeably. IGA is assessed via the intensity of the erythema and papulation/infiltration and gives a general impression of severity or improvement of AD over time. The IGA was originally developed to assess the disease severity within clinical trials and is one of the standard parameters collected to assess treatment success. In recent time, IGA is more commonly used in clinical practice to guide treatment decisions for physicians and document the impact of the clinical treatment over time. 

 

Validation of questionnaire

paper version: yes            digital version: no

How to use the eIGA for atopic dermatitis

The IGA should only be used by trained physicians. IGA for AD is assessed by the intensity of the erythema and papulation/infiltration and ranges from clear (0), almost clear (1), mild (2), moderate (3), to severe (4) and very severe disease (6). Each severity grade is distinctly defined by a relevant morphologic description to ensure comparability of IGA scores between health care providers and over time.  

The eIGA for atopic dermatitis

The eIGA provides a quick and easy objective assessment of atopic dermatitis from the perspective of the treating physician using defined criteria.

 

The following versions of the eIGA for AD are available

eiga ios

iOS version
eiga android

Android version
eiga web

Web version
eiga pdf

Illustrative PDF

(coming soon)

eiga pdf or

Original PDF

(coming soon)

Features

use icon eiga ad

USER-FRIENDLY

eIGA is straightforward to use, thanks to the clear morphological description of the severity states.

rating icon eiga ad

SEVERITY MONITORING

Save your time with eIGA. In only few minutes you can get your IGA score without doing any calculations.

nature icon eiga ad

ENVIRONMENTALLY FRIENDY

Take care of the environment and save your patient data on the online platform or as PDF files for yourself and your physicians.

patient icon eiga ad

ACCURATE

The eIGA is recommended by international guideline associations for an accurate measure of severity of the dermatological disease.

platform icon eiga ad

ACCESSIBLE FROM ALL DEVICES

With DermaValue, your eIGA is always just a few clicks away. The application is available for PCs, tablets, smartphones, and other devices.

global icon eiga ad

MULTILINGUAL

The IGA is available in various languages, so choose the one you prefer and forget about language barriers.

 

 

References

 

Minimal Clinically Important Difference (MCID):

Silverberg, J. I., Lei, D., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., Kantor, R., & Hsu, D. Y. (2021). Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(1), 180–187. https://doi.org/10.1111/jdv.16846

 

Breuer et al. 2004 - Influence of Pimecrolimus Cream 1% on Different Morphological Signs of Eczema in Infants with Atopic Dermatitis; https://doi.org/10.1159/000080855

 

 

 

Our other tools

eeasi web
eflqa web
edlqi web
eitch web
eerlangeratopiescore web
enappa web
epain web
epasi web
epbi web
epbik web
epbiw web
epgaforacne web
epgaforpsoriasis web
epsosat web
esaeasi web
esapasi web
escorad web
ewoundqol web
dapsa web

Our partners

uke
psonet
cvderm
ddg2
bvd
de hautnetz